Ayrshire Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,782
Closed -$3.16M 57
2020
Q4
$3.16M Buy
15,782
+213
+1% +$43.3K 2.04% 24
2020
Q3
$3.41M Buy
15,569
+96
+0.6% +$20.3K 2.5% 17
2020
Q2
$2.95M Sell
15,473
-568
-4% -$99.5K 2.47% 17
2020
Q1
$2.49M Buy
+16,041
New +$1.87M 2.5% 17

Other funds holding TDOC

Ayrshire Capital Management's TDOC Position: Q1 2021 in Review

Ayrshire Capital Management sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 15,782 shares — an estimated $3.16M sold.

Ayrshire Capital Management first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $3.41M in Q3 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Ayrshire Capital Management reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Ayrshire Capital Management sold 15,782 Teladoc Health shares in Q1 2021, an estimated $3.16M.
  • Ayrshire Capital Management first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
  • Ayrshire Capital Management's Teladoc Health position peaked at $3.41M in Q3 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Ayrshire Capital Management's 13F filing for Q1 2021, filed 11 May 2021.